stockportfolio.pro
Phibro Animal Health Corporation (PAHC)
Healthcare · Drug Manufacturers - Specialty & Generic · NasdaqGM
Phibro Animal Health Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $751.53M | $764.28M | $819.98M | $828.00M | $800.35M | $833.35M | $942.26M | $977.90M | $1.02B | $1.30B |
| Gross profit | $239.03M | $248.24M | $266.88M | $264.62M | $256.88M | $271.38M | $285.40M | $298.24M | $313.09M | $399.94M |
| Net income | $82.73M | $64.61M | $64.88M | $54.71M | $33.55M | $54.38M | $49.17M | $32.60M | $2.40M | $48.30M |
| Net margin | 11.0% | 8.5% | 7.9% | 6.6% | 4.2% | 6.5% | 5.2% | 3.3% | 0.2% | 3.7% |
Source: Phibro Animal Health Corporation SEC filings (10-K). 14 years of history available in the interactive view.
Explore 14 years of Phibro Animal Health Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track PAHC in your portfolio →
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Phibro Animal Health Corporation — frequently asked questions
What is Phibro Animal Health Corporation's revenue?
Phibro Animal Health Corporation (PAHC) reported revenue of $1.30B for fiscal year 2025, up 27.4% from the prior year, according to its SEC filings.
Is Phibro Animal Health Corporation profitable?
Yes. PAHC earned net income of $48.30M in fiscal 2025, a net margin of 3.7%.
What is PAHC's P/E ratio?
Phibro Animal Health Corporation trades at a price-to-earnings ratio of about 13.6 based on the latest data in our nightly-refreshed cache.
How fast is Phibro Animal Health Corporation growing?
PAHC's revenue grew at roughly 10.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Phibro Animal Health Corporation's official SEC filings (10-K and 10-Q), covering 14 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.